Clinical Performance of One-shade Universal Dental Resin Composite as Posterior Restoration

Minia University40 enrolled

Overview

This study is aimed to evaluate the clinical performance of new One-shade universal composite resin as posterior restoration using US Public Health Service "USPSH" criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months.

One operator will place all restorations under rubber-dam isolation. The patients will receive restorations with both materials, randomly after shade selection (The shade of single shade universal resin composite "Omnichroma" will be taken before and after placement into the cavity). During the referred period, only the two composites in study will be placed in posterior teeth in the dental office. The various materials' application procedure will be applied according to manufacturer's instructions.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Carious Teeth

Interventions

US Public Health Service "USPSH" criteria for assessment of success of resin composite restorationsOTHER

US Public Health Service "USPSH" criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months.

Eligibility

Sex: ALLMin age: 25 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * • They should have an acceptable oral hygiene level. * Presence of at least two occlusal carious lesions to be restored with two different types of composite. * The two studied materials restorations should be used in approximately the same sized lesions or within the same extension. * Age range between 25 and 45years. Exclusion Criteria: * • Severe or active periodontal or carious disease and heavy bruxism or a traumatic occlusion * Patients with a compromised medical history, or had received therapeutic irradiation to the head and neck region. * Alcoholic and smoker patients. * Patients had participated in a clinical trial within 6 months before commencement of this trial. * Patients unable to return for recall appointment

Locations (1)

Ruba Salah Anwar

Minya, Egypt

Outcomes

Primary Outcomes

USPSH criteria

Alpha and Beta are clinically successful, Charlie and Delta are clinically failure

Time frame: For 9 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.